News > Resumption of BCG Vaccination advice

Dear All

The Ministry of Health anticipates the New Zealand Bacillus Calmette-Guerin (BCG) Programme will resume in late April, once continuous supply of vaccine has been confirmed and vaccine stock has been released.

Seqirus, the vaccine supplier, has notified PHARMAC that they expect to deliver sufficient supplies in late March/early April 2018, to enable New Zealand’s funded BCG immunisation programme to resume under the parameters described in chapter 20 of the New Zealand Immunisation Handbook.

To assist public health units with your preparations for the resumption of BCG vaccinations please see attached:

Advice to health professional :Resumption of BCG vaccinations

Seqirus letter dated 17 December 2017